Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 21, 2019

DrugPatentWatch Database Preview

PROLIA Drug Profile

« Back to Dashboard

Summary for Tradename: PROLIA

Patents:	75
Applicants:	1
BLAs:	1
Suppliers: see list	1
Drug Prices:	Drug price information for PROLIA

Pharmacology for PROLIA

Mechanism of Action	RANK Ligand Blocking Activity

US Patents for PROLIA

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Try a Free Trial	Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES)	➤ Try a Free Trial	RX	Orphan	search
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Try a Free Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	➤ Try a Free Trial	RX	Orphan	search
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Try a Free Trial	Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES)	➤ Try a Free Trial	RX	Orphan	search
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Try a Free Trial	CONCIEVALVE, LLC (Minneapolis, MN)	➤ Try a Free Trial	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for PROLIA

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Denmark	2849758	➤ Try a Free Trial
European Patent Office	2906237	➤ Try a Free Trial
Slovakia	288559	➤ Try a Free Trial
Portugal	946725	➤ Try a Free Trial
Country	Patent Number	Estimated Expiration

Supplementary Protection Certificates for PROLIA

Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
PA2010013	Lithuania	➤ Try a Free Trial	PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: EU/1/10/618/001, 2010 05 26, EU/1/10/618/002, 2010 05 26, EU/1/10/618/003, 2010 05 26, EU/1/10/618/004 20100526
2010/035	Ireland	➤ Try a Free Trial	PRODUCT NAME: DENOSUMAB (PROLIA ); NAT REGISTRATION NO/DATE: EU/1/10/618/001 20100526; FIRST REGISTRATION NO/DATE: EU/1/10/618/002 26/05/2010 IRELAND EU/1/10/618/003 26/05/2010 IRELAND EU/1/10/618/004 26/05/2010 IRELAND EU/1/10/618/001 26/05/2010 IRELAND EU/1/10/618/002 26/05/2010 IRELAND EU/1/10/618/003 26/05/2010 IRELAND EU/1/10/618/004 20100526
CA 2010 00033	Denmark	➤ Try a Free Trial
495	Finland	➤ Try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.